CSPC Pharmaceutical : RETIREMENT OF EXECUTIVE DIRECTOR

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

RETIREMENT OF EXECUTIVE DIRECTOR

The board of directors (the "Board") of CSPC Pharmaceutical Group Limited (the "Company") hereby announces that Mr. Wang Shunlong ("Mr. WANG"), an executive director of the Company, retired from office as executive director of the Company at the conclusion of the annual general meeting (the "AGM") of the Company held on 25 May 2017. Mr. WANG did not offer himself for re-election at the AGM in pursuit of his career development.

Mr. WANG has confirmed that he does not have any disagreement with the Board and there is no other matters related to his retirement that need to be brought to the attention of the shareholders of the Company.

The Board would like to take this opportunity to give appreciation to Mr. WANG for his tremendous contribution to the Company during his tenure of office.

By order of the board

CSPC Pharmaceutical Group Limited

CAI Dongchen

Chairman

Hong Kong, 25 May 2017

As at the date of this notice, the Board comprises Mr. CAI Dongchen, Mr. PAN Weidong, Mr. WANG Huaiyu, Mr. LU Jianmin, Mr. WANG Jinxu, Mr. WANG Zhenguo, Mr. LU Hua and Mr. CHAK Kin Man as executive Directors; Mr. LEE Ka Sze, Carmelo as non-executive Director and Mr. CHAN Siu Keung, Leonard, Mr. WANG Bo, Mr. LO Yuk Lam, Mr. YU Jinming and Mr. CHEN Chuan as independent non-executive Directors.